Visiting Professors


 

Anahita Dua, MD

Dr. Dua is a vascular surgeon at Massachusetts General Hospital and an Associate Professor of Surgery at Harvard Medical School. At Mass General, she is the director of the Vascular Lab, co-director of the Peripheral Artery Disease Center and Limb Evaluation and Amputation Program (LEAPP), associate director of the Wound Care Center, associate director of the Vascular Surgery Clerkship and director of clinical research for the division of vascular surgery. She specializes in advanced endovascular (minimally invasive) and traditional (open) limb salvage techniques for treating peripheral arterial disease and critical limb ischemia, diabetic limb disease, aortic disease, carotid disease, thoracic outlet syndrome and venous disease.

Dr. Dua completed her vascular surgery fellowship at Stanford University Hospital, her general surgery residency at the Medical College of Wisconsin and her medical school in the United Kingdom at the University of Aberdeen. She has also completed a master’s degree in trauma sciences, a master’s in business administration in health care management and has a certificate in health economics and outcomes research as well as a certificate in drug and device development from the Massachusetts Institute of Technology. She is board-certified in vascular surgery, general surgery and advanced wound care and management.

Dr. Dua has published over 150 peer reviewed papers and has edited five vascular surgery medical textbooks. She serves on multiple national vascular surgery committees through the Society for Vascular Surgery and other vascular organizations including the South Asian-American Vascular Society and American College of Surgeons. She is the president of the South Asian American Vascular Surgery Society.

Dr. Dua’s lab NIH-funded lab focuses on anticoagulation and biomarkers that are predictive of thrombosis and hemostasis in patients that have undergone revascularization. She is interested in creation precision, point of care medical approaches to anticoagulation for patients post revascularization. Her clinical and outcomes research focuses primarily on diseases involving peripheral vascular disease, limb salvage and critical limb ischemia. She is part of a technology development team that creates tools to increase walking distance and wound healing while decreasing pain in patients with peripheral vascular disease. Dr. Dua is also involved heavily in surgical outcomes-based research using large medical databases to generate both quality outcomes and cost effectiveness data.

Dr. Dua is a self-described animal lover and rescuer of pitbulls. At one point, she housed 14 pitbull puppies and their mother at once. Nowadays, her spare time is spent with her husband, son, daughter and dog Leo.


 

Jason T. Lee, MD

Dr. Lee is the chief of vascular surgery for Stanford Medicine. He is a fellowship-trained, board-certified vascular surgeon and a world-renowned leader in the field.

He has a strong “patient first” philosophy of care. For every case, he emphasizes the most advanced, minimally invasive diagnostic and treatment approaches. He works closely with a multidisciplinary team of specialists to ensure that each care plan is personalized, precise, compassionate, and comprehensive.

Dr. Lee also is passionate about educating and mentoring tomorrow’s vascular surgeons. He is a professor of surgery at Stanford University School of Medicine. He serves as past president of the Vascular and Endovascular Surgery Society and is current president of the Association of Program Directors in Vascular Surgery.

Other leadership roles have been in the Society for Vascular Surgery, the Society for Clinical Vascular Surgery, National Comprehensive Cancer Network, American Heart Association, and American Board of Surgery.

Dr. Lee champions clinical and translational research. His research findings have helped advance minimally invasive endovascular aneurysm repair (EVAR) and other surgical procedures.
He has made nearly 600 presentations worldwide, including 200 peer-reviewed abstract presentations at meetings of the Society for Vascular Surgery, American Association for Thoracic Surgery, and other conferences.

He has co-authored dozens of book chapters and published more than 200 articles on innovations in the treatment of aortic aneurysms, vascular trauma, deep vein thrombosis, and athletic vascular disorders. His work has appeared in the Journal of Vascular Surgery, Annals of Surgery, JAMA Surgery, and other peer-reviewed journals.

Dr. Lee has earned extensive recognition for his achievements. The Vascular and Endovascular Surgery Society, Society for Vascular Surgery, National Institutes of Health, Robert Wood Johnson Foundation, and many other organizations have honored his work.

He is a member of the American Surgical Association, Society for Vascular Surgery, International Society of Endovascular Specialists, and other professional societies.


 


David A. Rigberg, MD

Dr. Rigberg is an Associate Professor of Surgery in the Division of Vascular Surgery at the David Geffen School of Medicine at UCLA. He earned his bachelor’s degree at the University of Pennsylvania and his medical degree at the University of Arizona in Tucson. He completed his internship and residency in general surgery at UCLA, and then was the vascular fellow at UCLA as well. This training included open vascular surgery as well as catheter-based endovascular interventions.

Dr. Rigberg has published extensively in the basic and clinical sciences, including work in the field of outcomes from aortic operations.

He has also written on a variety of topics, including Takayasu’s arteritis and Thoracic Outlet Syndrome. Other research interests include the development of new devices for vascular procedures using thin-film Nitinol, work for which he recently received a one million dollar NIH Grant.
Dr. Rigberg is a full-time faculty member at UCLA, and is also the section chief of vascular surgery at Santa Monica-UCLA Hospital, with a practice encompassing all aspects of open and endovascular interventions.

In addition, he has an appointment at the Veterans’ Administration Hospital.